Stocktoria
PRO DEX INC PDEX
PRO DEX INC (PDEX) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $77.5M at a 17.6% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -1.7 — elevated (above the −1.78 line — aggressive-accounting signals worth a closer look) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 2036 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.534 |
| Retained earnings / assets | 0.587 |
| EBIT / assets | 0.175 |
| Equity / liabilities | 1.492 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| PDEX | PRO DEX INC | 6/9 | 8.16 | 14.4 | +16.5% |
| SGHT | Sight Sciences, Inc. | 5/9 | -5.95 | — | -3.1% |
| TELA | TELA Bio, Inc. | 3/9 | -13.97 | — | +15.8% |
| RCEL | AVITA Medical, Inc. | 3/9 | — | — | +11.5% |
| IRMD | IRADIMED CORP | 5/9 | 14.84 | 53.4 | +14.4% |
| DCTH | DELCATH SYSTEMS, INC. | 6/9 | 1.26 | 165.4 | +129.1% |
| LUNG | Pulmonx Corp | 3/9 | -11.04 | — | +8% |
About PRO DEX INC
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
FAQ
Is PDEX financially healthy?
PRO DEX INC's Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does PDEX pay a dividend?
No, PRO DEX INC does not currently pay a dividend.
How profitable is PDEX?
In FY2025, PRO DEX INC had a net margin of 17.6% and a return on equity of 28.7%.
Is PDEX overvalued or undervalued?
PRO DEX INC trades at about 17.4× trailing earnings — above its 10-year norm (10-year range 5.0×–33.7×, median 14.7×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for PDEX?
The average Wall-Street price target for PRO DEX INC is $70.00, about 2.5% below the recent price, from 1 analysts.
Is PDEX a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on PRO DEX INC: a Piotroski F-score of 6/9, an Altman Z″ in the safe zone, a P/E of about 14.4×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.